Access cutting-edge lennox-gastaut syndrome treatment through this clinical trial at a research site in Gulf Breeze. Study-provided care at no cost to qualified participants.
Access lennox-gastaut syndrome specialists in Gulf Breeze at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lennox-gastaut syndrome treatment provided free
This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.
Sponsor: Longboard Pharmaceuticals
Check if you qualify for this lennox-gastaut syndrome clinical trial in Gulf Breeze, FL
If you're searching for lennox-gastaut syndrome treatment options in Gulf Breeze, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gulf Breeze research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lennox-gastaut syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.